The first was a multi-center study that used data from 33,021 participants and found that GLP-1/GIP agonist and SGLT2 inhibitor use were associated with comparable rates of new retinopathy development and worsening of existing nonproliferative retinopathy
Apart from monetary considerations, many patients are choosing Wegovy for several other reasons: Heart health advantages: Wegovy is uniquely approved for lowering the likelihood of major cardiovascular events in people with existing heart disease, even if they do not lose substantial weight
Wegovy Summary of Product Characteristics (SmPC), Section 4.8
Overall, while many people lose weight on Topamax, some others do not
Call/Text our clinic at (801) 318-4260 to discuss if PT-141+ Peptides align with your therapy goals.
Individuals who experience an adverse health event after taking Ozempic, such as gastroparesis, vision loss, or blood clots, may be eligible for compensation